iCardiac Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
21
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
8
- Investments
-
1
iCardiac General Information
Description
Provider of on-demand expertise for cardiac safety and respiratory services intended to help drug development programs run more efficiently. The company's on-demand expertise for cardiac safety and respiratory services includes precision QT methodologies that set a new standard for precision and accuracy in all phases of human drug trials, to ensure that subjects are not inappropriately included or excluded from studies, enabling small and mid-sized pharma and biotech companies to advance in the field of cardiac safety.
Contact Information
Website
www.icardiac.comCorporate Office
- 150 Allens Creek
- Rochester, NY 14618
- United States
Corporate Office
- 150 Allens Creek
- Rochester, NY 14618
- United States
iCardiac Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
iCardiac Comparisons
Industry
Financing
Details
iCardiac Competitors (15)
One of iCardiac’s 15 competitors is PerkinElmer, a Private Equity-Backed company based in Shelton, CT.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
PerkinElmer | Private Equity-Backed | Shelton, CT | ||||
Pharmaceutical Product Development | Formerly PE-Backed | Wilmington, NC | ||||
CTI Clinical Trial and Consulting | Private Equity-Backed | Covington, KY | ||||
Clario (United States) | Private Equity-Backed | Philadelphia, PA | ||||
Parexel International | Private Equity-Backed | Durham, NC |
iCardiac Patents
iCardiac Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20130096447-A1 | System and methods for serial analysis of electrocardiograms | Inactive | 27-Sep-2011 | ||
US-20110184296-A1 | Method and system for quantitative assessment of cardiac electrical events | Inactive | 27-Jan-2010 | ||
US-20110184300-A1 | Atrial fibrillation detection based on absence of consistent p-loops in averaged vectorcardiogram | Inactive | 26-Jan-2010 | ||
US-20110112414-A1 | System for automated ekg analysis | Inactive | 06-Nov-2009 | ||
US-20110112413-A1 | Method for automated ekg analysis | Inactive | 06-Nov-2009 | A61B5/341 |
iCardiac Signals
iCardiac Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
iCardiac Acquisitions (1)
iCardiac’s most recent deal was a Merger/Acquisition with nSpire Health (clinical trials division). The deal was made on 06-Aug-2015.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
nSpire Health (clinical trials division) | 06-Aug-2015 | Merger/Acquisition | Other Healthcare Services |
iCardiac FAQs
-
When was iCardiac founded?
iCardiac was founded in 2006.
-
Where is iCardiac headquartered?
iCardiac is headquartered in Rochester, NY.
-
What is the size of iCardiac?
iCardiac has 21 total employees.
-
What industry is iCardiac in?
iCardiac’s primary industry is Laboratory Services (Healthcare).
-
Is iCardiac a private or public company?
iCardiac is a Private company.
-
What is iCardiac’s current revenue?
The current revenue for iCardiac is
. -
How much funding has iCardiac raised over time?
iCardiac has raised $9.1M.
-
Who are iCardiac’s investors?
Advantage Capital, Brian Model, Empire State Development, National Institutes of Health, and New York State Common Retirement Fund are 5 of 12 investors who have invested in iCardiac.
-
Who are iCardiac’s competitors?
PerkinElmer, Pharmaceutical Product Development, CTI Clinical Trial and Consulting, Clario (United States), and Parexel International are some of the 15 competitors of iCardiac.
-
When was iCardiac acquired?
iCardiac was acquired on 04-Dec-2017.
-
Who acquired iCardiac?
iCardiac was acquired by Clario (United States).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »